125 related articles for article (PubMed ID: 10882868)
1. Molecular and clinical risk markers in colon cancer trials.
Hill MJ
Eur J Cancer; 2000 Jun; 36(10):1288-91. PubMed ID: 10882868
[TBL] [Abstract][Full Text] [Related]
2. Large bowel adenomas: markers of risk and endpoints.
Baron JA
J Cell Biochem Suppl; 1996; 25():142-8. PubMed ID: 9027611
[TBL] [Abstract][Full Text] [Related]
3. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention in hereditary colorectal cancer syndromes.
Hawk E; Lubet R; Limburg P
Cancer; 1999 Dec; 86(11 Suppl):2551-63. PubMed ID: 10630181
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
6. The first mutations in the MYH gene reported in Moroccan colon cancer patients.
Laarabi FZ; Cherkaoui Jaouad I; Baert-Desurmont S; Ouldim K; Ibrahimi A; Kanouni N; Frebourg T; Sefiani A
Gene; 2012 Mar; 496(1):55-8. PubMed ID: 22266422
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for inherited colorectal cancer.
Lynch PM
Expert Opin Pharmacother; 2010 May; 11(7):1101-8. PubMed ID: 20345333
[TBL] [Abstract][Full Text] [Related]
8. Colorectal tumourigenesis.
Peiser J; Smith A; Bapat B; Stern H
Surg Oncol; 1994 Aug; 3(4):195-201. PubMed ID: 7834110
[TBL] [Abstract][Full Text] [Related]
9. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention with special reference to inherited colorectal cancer.
Lynch PM
Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
[TBL] [Abstract][Full Text] [Related]
11. Cohorts with familial disposition for colon cancers in chemoprevention trials.
Burt RW
J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609
[TBL] [Abstract][Full Text] [Related]
12. Evolution of hereditary bowel cancer.
Jass JR
Mutat Res; 1993 Nov; 290(1):13-25. PubMed ID: 7694093
[TBL] [Abstract][Full Text] [Related]
13. A multi-stage model of adenoma development.
Pinsky PF
J Theor Biol; 2000 Nov; 207(2):129-43. PubMed ID: 11034825
[TBL] [Abstract][Full Text] [Related]
14. APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis.
Ficari F; Cama A; Valanzano R; Curia MC; Palmirotta R; Aceto G; Esposito DL; Crognale S; Lombardi A; Messerini L; Mariani-Costantini R; Tonelli F; Battista P
Br J Cancer; 2000 Jan; 82(2):348-53. PubMed ID: 10646887
[TBL] [Abstract][Full Text] [Related]
15. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
[TBL] [Abstract][Full Text] [Related]
16. Precancerous colorectal lesions (Review).
Conteduca V; Sansonno D; Russi S; Dammacco F
Int J Oncol; 2013 Oct; 43(4):973-84. PubMed ID: 23900573
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps.
Leppert M; Burt R; Hughes JP; Samowitz W; Nakamura Y; Woodward S; Gardner E; Lalouel JM; White R
N Engl J Med; 1990 Mar; 322(13):904-8. PubMed ID: 2156161
[TBL] [Abstract][Full Text] [Related]
18. Colonic and duodenal flat adenomas in children with classical familial adenomatous polyposis.
Cohen M; Thomson M; Taylor C; Donatone J; Quijano G; Drut R
Int J Surg Pathol; 2006 Apr; 14(2):133-40. PubMed ID: 16703174
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers.
Ghorbanoghli Z; Nieuwenhuis MH; Houwing-Duistermaat JJ; Jagmohan-Changur S; Hes FJ; Tops CM; Wagner A; Aalfs CM; Verhoef S; Gómez García EB; Sijmons RH; Menko FH; Letteboer TG; Hoogerbrugge N; van Wezel T; Vasen HF; Wijnen JT
Fam Cancer; 2016 Oct; 15(4):563-70. PubMed ID: 26880076
[TBL] [Abstract][Full Text] [Related]
20. Potential pitfalls in the use of surrogate endpoints in colorectal adenoma chemoprevention.
Levin B
J Natl Cancer Inst; 2003 May; 95(10):697-9. PubMed ID: 12759378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
